LAS VEGAS, July 17, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) has signed a Consulting Services Agreement with Worldwide Clinical Trials, Inc. to evaluate the company's intellectual property portfolio
Growth Capitalist (https://growthcapitalist.com/2017/07/gb-sciences-initiates-cannabis-based-therapy-clinical-trials-consulting-services-agreement-with-worldwide-clinical-trials-inc/)
LAS VEGAS, July 17, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) has signed a Consulting Services Agreement with Worldwide Clinical Trials, Inc. to evaluate the company's intellectual property portfolio